The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Resveratrol: Preventing properties against vascular alterations and ageing
Abstract
Cardiovascular diseases are the leading cause of death in developed countries where the common pathological substrate underlying this process is atherosclerosis. Several new concepts have emerged in relation to mechanisms that contribute to the regulation of the vascular diseases and associated inflammatory effects. Recently, potential antioxidants (vitamin E, polyphenols) have received much attention as potential anti-atherosclerotic agents. Among the polyphenols with health benefic properties, resveratrol, a phytoalexin of grape, seem to be a good candidate protecting the vascular walls from oxidation, inflammation, platelet aggregation, and thrombus formation. In this review, we focus on the mechanism of resveratrol cardiovascular benefic effects. We analyze, in relation with the different steps of atherosclerotic process, the resveratrol properties at multiple levels, such as cellular signaling, enzymatic pathways, apoptosis, and gene expression. We show and discuss the relationship with reactive oxygen species, regulation of pro-inflammatory genes including cycloxygenases and cytokines in molecular inflammatory and aging processes, and how the regulation of these activites by resveratrol can lead to a prevention of vascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Ushio-Fukai, M., Tang, Y., Fukai, T., Dikalov, S. I., Ma, Y., Fujimoto, M., Quinn, M. T., Pagano, P. J., Johnson, C., & Alexander, R. W. (2002) · Circulation Research · doi:10.1161/01.res.0000046227.65158.f8 · Cited by 463
RetractedA novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
Xie, Q. W., Kashiwabara, Y., & Nathan, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37600-7 · Cited by 2,212
HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS
Walle, T., Hsieh, F., DeLegge, M. H., Oatis, J. E., & Walle, U. K. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000885 · Cited by 1,880
Sirtuin activators mimic caloric restriction and delay ageing in metazoans
Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., & Sinclair, D. (2004) · Nature · doi:10.1038/nature02789 · Cited by 1,868
Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine
Frankel, E. N., German, J. B., Kinsella, J. E., Parks, E., & Kanner, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)90206-v · Cited by 1,647
Tyrosine Kinase Inhibition: An Approach to Drug Development
Levitzki, A., & Gazit, A. (1995) · Science · doi:10.1126/science.7892601 · Cited by 1,635
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004) · PubMed · Cited by 1,395
Guanylyl Cyclases and Signaling by Cyclic GMP
Lucas, K. A., Pitari, G. M., Kazerounian, S., Ruiz-Stewart, I., Park, J., Schulz, S., Chepenik, K. P., & Waldman, S. A. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01457-1 · Cited by 1,224
Minireview: The Adipocyte—At the Crossroads of Energy Homeostasis, Inflammation, and Atherosclerosis
Rajala, M. W., & Scherer, P. E. (2003) · Endocrinology · doi:10.1210/en.2003-0580 · Cited by 1,190
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Inhibition of human LDL oxidation by resveratrol
Frankel, E. N., Waterhouse, A. L., & Kinsella, J. E. (1993) · The Lancet · doi:10.1016/0140-6736(93)92472-6 · Cited by 887
Manna, S. K., Mukhopadhyay, A., & Aggarwal, B. B. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6509 · Cited by 879
Pace-Asciak, C. R., Hahn, S., Diamandis, E. P., Soleas, G., & Goldberg, D. M. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06045-1 · Cited by 874
Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., & Dannenberg, A. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21875 · Cited by 786
Davı̀, G., Ciabattoni, G., Consoli, A., Mezzetti, A., Falco, A., Santarone, S., Pennese, E., Vitacolonna, E., Bucciarelli, T., Costantini, F., et al. (1999) · Circulation · doi:10.1161/01.cir.99.2.224 · Cited by 742
NF-κB: pivotal mediator or innocent bystander in atherogenesis?
Collins, T., & Cybulsky, M. I. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10373 · Cited by 727
Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway
Lee, F. S., Hagler, J., Chen, Z. J., & Maniatis, T. (1997) · Cell · doi:10.1016/s0092-8674(00)81842-5 · Cited by 707
Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., & Förstermann, U. (2002) · Circulation · doi:10.1161/01.cir.0000029925.18593.5c · Cited by 666
Yamamoto, K., Arakawa, T., Ueda, N., & Yamamoto, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31315 · Cited by 647
Role of vitamin E in preventing the oxidation of low-density lipoprotein
Esterbauer, H., Dieber-Rotheneder, M., Striegl, G., & Waeg, G. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.1.314s · Cited by 641
Carluccio, M. A., Siculella, L., Ancora, M. A., Massaro, M., Scoditti, E., Storelli, C., Visioli, F., Distante, A., & De Caterina, R. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000062884.69432.a0 · Cited by 640
Touyz, R. M., Chen, X., Tabet, F., Yao, G., He, G., Quinn, M. T., Pagano, P. J., & Schiffrin, E. L. (2002) · Circulation Research · doi:10.1161/01.res.0000020404.01971.2f · Cited by 590
Kim, H. K., Cheon, B. S., Kim, Y. H., Kim, S. Y., & Kim, H. P. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00160-4 · Cited by 546
Tsai, S., Lin‐Shiau, S., & Lin, J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702357 · Cited by 511
Holmes-McNary, M. Q., & Baldwin, A. S. (2000) · PubMed · doi:10.17615/wdcc-wb89 · Cited by 498
Reactive oxygen generated by Nox1 triggers the angiogenic switch
Arbiser, J. L., Petros, J., Klafter, R., Govindajaran, B., McLaughlin, E. R., Brown, L. F., Cohen, C., Moses, M., Kilroy, S., Arnold, R. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.022630199 · Cited by 489
Fauconneau, B., Waffo-Teguo, P., Huguet, F., Barrier, L., Decendit, A., & Merillon, J.-M. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00883-7 · Cited by 438
Screening of medicinal plant extracts for antioxidant activity
Lee, S. E., Hwang, H. J., Ha, J.-S., Jeong, H.-S., & Kim, J. H. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00259-5 · Cited by 426
Fruchart, J.-C., Duriez, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199906000-00007 · Cited by 425
Martinez, J., & Moreno, J. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00380-9 · Cited by 408
Kawada, N., Seki, S., Inoue, M., & Kuroki, T. (1998) · Hepatology · doi:10.1002/hep.510270512 · Cited by 397
Inhibition of cancer growth by resveratrol is related to its low bioavailability
Asensi, M., Medina, I., Ortega, A., Carretero, J., Baño, M. C., Obrador, E., & Estrela, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00911-5 · Cited by 388
Augmented Expression of Cyclooxygenase-2 in Human Atherosclerotic Lesions
Schönbeck, U., Sukhova, G. K., Graber, P., Coulter, S., & Libby, P. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65230-3 · Cited by 379
Screening of medicinal plant extracts for antioxidant activity
Prakash, V., Kishor, M. P., & Meenakshi, M. (2009) · Journal of Medicinal Plants Research · doi:10.5897/jmpr.9001114 · Cited by 373
Antiplatelet activity of synthetic and natural resveratrol in red wine.
Bertelli, A., Giovannini, L., Giannessi, D., MIGLIORI, M., Bernini, W., Fregoni, M., & Bertelli, A. A. A. (1995) · PubMed · Cited by 361
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms
Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S., Leung, R. H. F., Ito, K., Russell, R. E. K., & Barnes, P. J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00110.2004 · Cited by 361
Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta
Ke Chen, C., & Pace-Asciak, C. R. (1996) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)02001-2 · Cited by 343
Brâkenhielm, E., Cao, R., & Cao, Y. (2001) · The FASEB Journal · doi:10.1096/fj.01-0028fje · Cited by 334
Frémont, L., Belguendouz, L., & Delpal, S. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00209-x · Cited by 333
Andriambeloson, E., Kleschyov, A. L., Muller, B., Beretz, A., Stoclet, J. C., & Andriantsitohaina, R. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701011 · Cited by 323
Wines and grape juices as modulators of platelet aggregation in healthy human subjects
Pace-Asciak, C. R., Rounova, O., Hahn, S. E., Diamandis, E. P., & Goldberg, D. M. (1996) · Clinica Chimica Acta · doi:10.1016/0009-8981(96)06236-5 · Cited by 316
Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B. (2004) · Oncogene · doi:10.1038/sj.onc.1208169 · Cited by 310
Wadsworth, T. L., & Koop, D. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00002-7 · Cited by 302
Bastianetto, S., Zheng, W., & Quirion, R. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703626 · Cited by 302
Belguendouz, L., Fremont, L., & Linard, A. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00820-9 · Cited by 299
Molecular inflammation hypothesis of aging based on the anti‐aging mechanism of calorie restriction
Chung, H. Y., Kim, H. J., Kim, K. W., Choi, J. S., & Yu, B. P. (2002) · Microscopy Research and Technique · doi:10.1002/jemt.10203 · Cited by 297
Baker, C. S. R., Hall, R. J. C., Evans, T. J., Pomerance, A., Maclouf, J., Creminon, C., Yacoub, M. H., & Polak, J. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.3.646 · Cited by 296
Beyond alcohol: Beverage consumption and cardiovascular mortality
Goldberg, D. M., Hahn, S. E., & Parkes, J. G. (1995) · Clinica Chimica Acta · doi:10.1016/0009-8981(95)06069-p · Cited by 290
Murias, M., Handler, N., Erker, T., Pleban, K., Ecker, G., Saiko, P., Szekeres, T., & Jäger, W. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.08.008 · Cited by 288
Prostaglandin H Synthase and Xenobiotic Oxidation
Eling, T. E., Thompson, D. C., Foureman, G. L., Curtis, J. F., & Hughes, M. F. (1990) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.000245 · Cited by 282
Stojanović, S., Sprinz, H., & Brede, O. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2001.2388 · Cited by 274
Effects of stilbenes on arachidonate metabolism in leukocytes
Yoshiyuki, K., Hiromichi, O., & Shigeru, A. (1985) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(85)90167-5 · Cited by 273
Hsieh, T. C., Juan, G., Darżynkiewicz, Z., & WU, J. M. (1999) · PubMed · Cited by 262
Gao, X., Xu, Y. X., Janakiraman, N., Chapman, R. A., & Gautam∗, S. C. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00775-4 · Cited by 252
Orallo, F., Álvarez, E., Camiña, M., Leiro, J. M., Gómez, E., & Fernández, P. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12861-1 · Cited by 250
Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro
Wang, Z., Huang, Y., Zou, J., Cao, K., Xu, Y., & Wu, J. (2002) · International Journal of Molecular Medicine · doi:10.3892/ijmm.9.1.77 · Cited by 244
Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotilio, D., De Gaetano, G., Evangelista, V., & Cerletti, C. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701784 · Cited by 240
Kinase Inhibitors from Polygonum cuspidatum
Jayatilake, G. S., Jayasuriya, H., Lee, E.-S., Koonchanok, N. M., Geahlen, R. L., Ashendel, C. L., McLaughlin, J. L., & Chang, C.-J. (1993) · Journal of Natural Products · doi:10.1021/np50100a021 · Cited by 233
Inoue, H., Jiang, X.-F., Katayama, T., Osada, S., Umesono, K., & Namura, S. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.09.001 · Cited by 232
Cao, Z., & Li, Y. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.031 · Cited by 229
Lycopene, Tomatoes, and the Prevention of Coronary Heart Disease
Rao, A. V. (2002) · Experimental Biology and Medicine · doi:10.1177/153537020222701011 · Cited by 226
Cancer chemopreventive activity of resveratrol.
Jang, M., & Pezzuto, J. M. (1999) · PubMed · Cited by 225
Drake, T. A., Hannani, K. K., Fei, H. H., Lavi, S., & Berliner, J. A. (1991) · PubMed Central · Cited by 223
Kulmacz, R. J., & Wang, L.-H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24019 · Cited by 218
JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action?
Karin, M., & Delhase, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9067 · Cited by 214
Neutrophil‐mediated Vascular Injury
HARLAN, J. M. (1987) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1987.tb09912.x · Cited by 209
Adhami, V. M., Afaq, F., & Ahmad, N. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80019-2 · Cited by 209
Lin, M.-T., Yen, M.-L., Lin, C.-Y., & Kuo, M.-L. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1029 · Cited by 208
Pendurthi, U. R., Williams, J. T., & Rao, L. V. M. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.2.419 · Cited by 202
Resveratrol prevents apoptosis in K562 cells by inhibiting lipoxygenase and cyclooxygenase activity
Maccarrone, M., Lorenzon, T., Guerrieri, P., & Agrò, A. F. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00630.x · Cited by 195
Wyke, S. M., Russell, S. T., & Tisdale, M. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602165 · Cited by 184
Leiro, J., Álvarez, E., Arranz, J. A., Laguna, R., Uriarte, E., & Orallo, F. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1103561 · Cited by 183
Man-Ying Chan, M., Mattiacci, J. A., Hwang, H. S., Shah, A., & Fong, D. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00471-8 · Cited by 175
Jannin, B., Menzel, M., Berlot, J.-P., Delmas, D., Lançon, A., & Latruffe, N. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.04.028 · Cited by 175
Self-citationActivity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium
Ferrero, M. E., Bertelli, A. A., Fulgenzi, A., Pellegatta, F., Corsi, M. M., Bonfrate, M., Ferrara, F., Caterina, R. D., Giovannini, L., & Bertelli, A. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1208 · Cited by 173
Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol
Olson, E. R., Naugle, J. E., Zhang, X., Bomser, J. A., & Meszaros, J. G. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00763.2004 · Cited by 173
Shigematsu, S., Ishida, S., Hara, M., Takahashi, N., Yoshimatsu, H., Sakata, T., & Korthuis, R. J. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01430-2 · Cited by 171
Plasma and tissue resveratrol concentrations and pharmacological activity.
Bertelli, A., Bertelli, A. A. E., Gozzini, A., & Giovannini, L. (1998) · PubMed · Cited by 169
Cell-mediated immunity in atherosclerosis
Hansson, G. K. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199710000-00009 · Cited by 167
Modulation of redox-sensitive transcription factors by calorie restriction during aging
Kim, H. J., Jung, K. J., Yu, B. P., Cho, C. G., Choi, J. S., & Chung, H. Y. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(02)00094-5 · Cited by 166
Pal, S., Ho, N., Santos, C., Dubois, P., Mamo, J., Allister, E., & Croft, K. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.3.700 · Cited by 165
Miura, D., Miura, Y., & Yagasaki, K. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00469-7 · Cited by 165
The retardation of aging by caloric restriction: its significance in the transgenic era
Barger, J. L., Walford, R. L., & Weindruch, R. (2003) · Experimental Gerontology · doi:10.1016/j.exger.2003.10.017 · Cited by 160
The nuclear factor‐κB/inhibitor of kappa B autoregulatory system and atherosclerosis
Thurberg, B. L., & Collins, T. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00002 · Cited by 154
Bertelli, A., Giovannini, L., Stradi, R. D., Bertelli, A., & Tillement, J. P. (1996) · PubMed · Cited by 152
Interaction of Transresveratrol with Plasma Lipoproteins
Belguendouz, L., Frémont, L., & Gozzelino, M.-T. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00544-3 · Cited by 152
Jang, M., & Pezzuto, J. M. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00250-x · Cited by 148
Yu, R., Hebbar, V., Kim, D. W., Mandlekar, S., Pezzuto, J. M., & Kong, A.-N. T. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.217 · Cited by 140
Tsai, A., Kulmacz, R. J., & Palmer, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.18.10503 · Cited by 139
Bergamini, E., Cavallini, G., Donati, A., & Gori, Z. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(03)00048-9 · Cited by 138
Soliman, K. F. A., & MAZZIO, E. A. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-218-44309 · Cited by 135
Li, H. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00397-1 · Cited by 133
El‐Mowafy, A. M., & White, R. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00541-4 · Cited by 132
Waffo‐Téguo, P., Hawthorne, M., Cuendet, M., Mérillon, J., Kinghorn, A. D., Pezzuto, J. M., & Mehta, R. G. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc402_14 · Cited by 131
Yen, G., Duh, P., & Lin, C.-W. (2003) · Free Radical Research · doi:10.1080/1071576031000083099 · Cited by 130
Bertelli, A. A. E., Giovannini, L., Stradi, R., Urien, S., Tillement, J. P., & Bertelli, A. A. A. (1996) · PubMed · Cited by 120
Haider, U. G. B., Sorescu, D., Griendling, K. K., Vollmar, A. M., & Dirsch, V. M. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.4.772 · Cited by 119
Levenson, A. S., Gehm, B. D., Pearce, S. T., Horiguchi, J., Simons, L. A., Ward, J. E., Jameson, J. L., & Jordan, V. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.10992 · Cited by 115
Inhibition of protein kinase C by resveratrol
Slater, S. J., Seiz, J. L., Cook, A. C., Stagliano, B. A., & Buzas, C. J. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00214-4 · Cited by 113
Large-Conductance Ca2+-Activated K+ Channels:Physiological Role and Pharmacology
Wu, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457863 · Cited by 109
Class A Scavenger Receptor Up-regulation in Smooth Muscle Cells by Oxidized Low Density Lipoprotein
Mietus‐Snyder, M., Gowri, M. S., & Pitas, R. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.23.17661 · Cited by 108
Godichaud, S., Krisa, S., Couronné, B., Dubuisson, L., Mérillon, J., Desmoulière, A., & Rosenbaum, J. (2000) · Hepatology · doi:10.1053/he.2000.5848 · Cited by 105
de Brito, P. M., Almeida, L. M., & Dinis, T. C. P. (2002) · Free Radical Research · doi:10.1080/10715760290029083 · Cited by 102
Activation Loop Phosphorylation Controls Protein Kinase D-Dependent Activation of Nuclear Factor κB
Störz, P., Döppler, H. R., & Toker, A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.000687 · Cited by 102
Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells
Ruef, J., Moser, M., Kübler, W., & Bode, C. (2001) · Cardiovascular Pathology · doi:10.1016/s1054-8807(01)00095-3 · Cited by 100
Olas, B., Wachowicz, B., Saluk, J., & Zieliński, T. (2002) · Thrombosis Research · doi:10.1016/s0049-3848(02)00273-6 · Cited by 100
Flavonoids for reduction of atherosclerotic risk
Maron, D. J. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0119-1 · Cited by 98
Granados‐Soto, V., Argüelles, C. F., & Ortiz, M. I. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00130-2 · Cited by 98
Stewart, J. R., Ward, N. E., Ioannides, C. G., & O’Brian, C. A. (1999) · Biochemistry · doi:10.1021/bi990875u · Cited by 97
Resveratrol Is a Potent Inhibitor of the Dioxygenase Activity of Lipoxygenase
Pinto, M. C., García-Barrado, J. A., & Macı́as, P. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf990448n · Cited by 97
trans‐Resveratrol inhibits calcium influx in thrombin‐stimulated human platelets
Dobrydneva, Y., Williams, R. L., & Blackmore, P. F. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702749 · Cited by 95
Mizutani, K., Ikeda, K., & Yamori, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3097 · Cited by 94
Resveratrol Inhibits Cyclooxygenase‐2 Transcription in Human Mammary Epithelial Cells
Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., TELANG, N. T., & Dannenberg, A. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08737.x · Cited by 93
Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling
Leiro, J. M., Arranz, J. A., Fraiz, N., Sanmartín, M. L., Quezada, E., & Orallo, F. (2004) · International Immunopharmacology · doi:10.1016/j.intimp.2004.10.006 · Cited by 91
The effects of pH, osmolarity and urine contamination on equine spermatozoal motility
Griggers, S., Paccamonti, D. L., Thompson, R. A., & Eilts, B. E. (2001) · Theriogenology · doi:10.1016/s0093-691x(01)00593-3 · Cited by 91
Resveratrol Modulates Arachidonic Acid Release, Prostaglandin Synthesis, and 3T6 Fibroblast Growth
Moreno, J. J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39074-3 · Cited by 89
Inhibition of Cyclic Strain-Induced Endothelin-1 Gene Expression by Resveratrol
Liu, J., Chen, J., Chan, P., Cheng, C., & Cheng, T. (2003) · Hypertension · doi:10.1161/01.hyp.0000103162.76220.51 · Cited by 89
Effect of Red Wine on Endothelium-Dependent Relaxation in Rabbits
Cishek, M. B., Galloway, M. T., Karim, M., German, J. B., & Kappagoda, C. T. (1997) · Clinical Science · doi:10.1042/cs0930507 · Cited by 88
Zhong, M., Cheng, G. F., Wang, W., Guo, Y., Zhu, X. Y., & Zhang, J. T. (1999) · Phytomedicine · doi:10.1016/s0944-7113(99)80039-7 · Cited by 88
Kimura, Y., Okuda, H., & Kubo, M. (1995) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(94)01206-f · Cited by 86
Mizutani, K., Ikeda, K., Nishikata, T., & Yamori, Y. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018120-00018 · Cited by 83
Floreani, M., Napoli, E., Quintieri, L., & Palatini, P. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00179-6 · Cited by 79
Wang, M., Huang, H. M., Hsieh, S., Jeng, K. C., & Kuo, J. S. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00374-x · Cited by 77
García-García, J., Micol, V., de Godos, A. M., & Gómez-Fernández, J. C. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1507 · Cited by 75
Immunomodulatory activity of resveratrol: discrepant in vitro and in vivo immunological effects
Gao, X., Deeb, D., Media, J. E., Divine, G., Jiang, H., Chapman, R., & Gautam, S. C. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.08.008 · Cited by 74
Oxidized lipoproteins activate NF-κB binding activity and apoptosis in PC12 cells
Draczynska‐Lusiak, B., Chen, Y. M., & Sun, A. Y. (1998) · Neuroreport · doi:10.1097/00001756-199802160-00028 · Cited by 72
Modified forms of low density lipoprotein affect platelet aggregation
Aviram, M. (1989) · Thrombosis Research · doi:10.1016/0049-3848(89)90145-x · Cited by 71
Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells
Santo, A. D., Mezzetti, A., Napoleone, E., DITOMMASO, R., Donati, M. B., de Gaetano, G., & Lorenzet, R. (2003) · Journal of Thrombosis and Haemostasis · doi:10.1046/j.1538-7836.2003.00217.x · Cited by 70
Fukao, H., Ijiri, Y., Miura, M., Hashimoto, M., Yamashita, T., Fukunaga, C., Oiwa, K., Kawai, Y., Suwa, M., & Yamamoto, J. (2004) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-200408000-00001 · Cited by 70
Antioxidant activity of resveratrol in endotoxin-stimulated blood platelets
Olas, B., Wachowicz, B., Saluk, J., Zieliński, T., Kaca, W., & Buczyński, A. (2001) · Cell Biology and Toxicology · doi:10.1023/a:1010962222305 · Cited by 69
Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells.
Abou‐Agag, L. H., Aikens, M. L., Tabengwa, E. M., et al. (2001) · PubMed · Cited by 67
Pellegatta, F., Bertelli, A. A. E., Staels, B., Duhem, C., Fulgenzi, A., & Ferrero, M. E. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1220 · Cited by 67
Gehm, B. D., Levenson, A. S., Liu, H., Lee, E. J., Amundsen, B. M., Cushman, M., Jordan, V. C., & Jameson, J. L. (2004) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2003.12.002 · Cited by 65
Kaneider, N. C., Mosheimer, B. A., Reinisch, N., Patsch, J. R., & Wiedermann, C. J. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.020 · Cited by 64
Gong, Q., & Pitas, R. E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.37.21672 · Cited by 63
Effect of resveratrol on some activities of isolated and in whole blood human neutrophils
Cavallaro, A., Ainis, T., Bottari, C. O., & Fimiani, V. (2003) · Physiological Research · doi:10.33549/physiolres.930364 · Cited by 63
Zou, J., Huang, Y., Chen, Q., Wang, N., Cao, K., Hsieh, T. ‐., & Wu, J. M. (1999) · International Journal of Oncology · doi:10.3892/ijo.15.4.647 · Cited by 62
Polyphenolics Increase t‐PA and u‐PA Gene Transcription in Cultured Human Endothelial Cells
Abou‐Agag, L. H., Aikens, M. L., Tabengwa, E. M., et al. (2001) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2001.tb02193.x · Cited by 62
Bruder, J. L., Hsieh, T., Lerea, K. M., Olson, S. C., & WU, J. M. (2001) · BMC Cell Biology · doi:10.1186/1471-2121-2-1 · Cited by 61
Liu, Y., & Liu, G.-T. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.09.025 · Cited by 60
Mnjoyan, Z. H., & Fujise, K. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.023 · Cited by 60
Blache, D., Rustan, I., Durand, P. M., Lesgards, G., & Loreau, N. (1997) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(97)00383-6 · Cited by 59
Haider, U. G. B., Sorescu, D., Griendling, K. K., Vollmar, A. M., & Dirsch, V. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.4.925 · Cited by 59
Suppression of IL-8 gene transcription by resveratrol in phorbol ester treated human monocytic cells
Shen, F., Chen, S., Dong, X., Zhong, H., Li, Y.-T., & Cheng, G.-F. (2003) · Journal of Asian Natural Products Research · doi:10.1080/1028602031000066852 · Cited by 58
Resveratrol inhibits TNF alpha-induced endothelial cell activation.
Bertelli, A. A. E., Baccalini, R., Battaglia, E., Falchi, M., & Ferrero, M. E. (2001) · PubMed · Cited by 58
Effects of resveratrol on lymphocyte proliferation and cytokine release.
BOSCOLO, P., Signore, A. D., Sabbioni, E., Gioacchino, M. D., Giampaolo, L. D., Reale, M., Conti, P., Paganelli, R., & Giaccio, M. (2003) · PubMed · Cited by 57
Aging: gene silencing or gene activation?
Burzynski, S. R. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.06.010 · Cited by 54
Separation of Biologically Active Lipids from Red Wine
Fragopoulou, E., Nomikos, T., Antonopoulou, S., et al. (2000) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf990554p · Cited by 51
Anti-platelet effects of different phenolic compounds from Yucca schidigera Roezl. Bark
Olas, B., Wachowicz, B., Stochmal, A., et al. (2002) · Platelets · doi:10.1080/09533710022149386 · Cited by 49
Maccarrone, M., Putti, S., & Finazzi‐Agrò, A. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00643-1 · Cited by 46
Cited by
Nutraceuticals: Facts and fiction
Espín, J. C., García-Conesa, M. T., & Tomás-Barberán, F. A. (2007) · Phytochemistry · doi:10.1016/j.phytochem.2007.09.014 · Cited by 811
Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications
de la Lastra, C. A., & Villegas, I. (2007) · Biochemical Society Transactions · doi:10.1042/bst0351156 · Cited by 740
Ververidis, F., Trantas, E., Douglas, C., Vollmer, G., Kretzschmar, G., & Panopoulos, N. (2007) · Biotechnology Journal · doi:10.1002/biot.200700084 · Cited by 490
Resveratrol and Cardiovascular Diseases
Bonnefont-Rousselot, D. (2016) · Nutrients · doi:10.3390/nu8050250 · Cited by 442
Sirtuins — novel therapeutic targets to treat age-associated diseases
Lavu, S., Boss, O., Elliott, P. J., & Lambert, P. D. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2665 · Cited by 426
Metadata
- Authors
- Delmas, D., Jannin, B., & Latruffe, N.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 49
- Issue
- 5
- Pages
- 377-395
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2161585328
- Cited by
- 269
- References
- 156
- FWCI
- 9.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.